Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 345Gastrointestinal 12Gynecologic 10Breast 7Head & Neck 6Genitourinary 6CNS 6Dermatologic 3Sarcoma 2NET 2Endocrine 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Retinoblastoma 26Advanced Solid Tumors 18Mesothelioma 16Mesothelioma, Malignant 15Unspecified Adult Solid Tumor, Protocol Specific 13Solid Tumors 9Advanced Solid Tumor 6Neuroblastoma 4Unspecified Childhood Solid Tumor, Protocol Specific 3Solid Tumor 3Sarcoma 3Retinal Neoplasms 3Ovarian Neoplasms 3Neoplasms 3Medulloblastoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Wilms Tumor 2Testicular Neoplasms 2Solid Tumor, Adult 2Rhabdoid Tumor 2Relapsed Pediatric Solid Tumor 2Osteosarcoma 2Optic Nerve Glioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma 2Choroid Plexus Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Astrocytoma 2

Interventions

Cyclophosphamide 6pembrolizumab 5Cisplatin 4sargramostim 3Pemetrexed 3Decitabine 3Celecoxib 3fludarabine 2belinostat 2SS1(dsFv)PE38 2Quality of Life 2Plicamycin 2Nivolumab 2Ipilimumab 2FANG vaccine 2Drug Therapy 2perflutren 1olaparib 1niraparib 1iodixanol 1incomplete Freund's adjuvant 1fludarabine phosphate 1dostarlimab 1anetumab ravtansine 1aldesleukin 1alanosine 1Vorinostat 1Valacyclovir 1UV1 vaccine 1Tumor Burden 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Carboplatin × Other solid neoplasm × Clear all
NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡